4//SEC Filing
Baker Bros. Advisors (GP) LLC 4
Accession 0001144204-15-037662
CIK 0001070494other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:35 PM ET
Size
18.3 KB
Accession
0001144204-15-037662
Insider Transaction Report
Form 4
BAKER BROS. ADVISORS LP
10% Owner
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2015-06-15+12,500→ 12,500 total(indirect: See Footnote)Exercise: $39.06Exp: 2025-06-15→ Common Stock (12,500 underlying)
Footnotes (2)
- [F1]12,500 non-qualified stock options ("Stock Options") convertible solely into common shares were granted to Dr. Stephen R. Biggar, an employee of Baker Bros. Advisors LP (the "Adviser") in his capacity as a director of ACADIA Pharmaceuticals, Inc. (the "Issuer"). The Stock Options with a strike price of $39.06 vest in 4 equal quarterly installments beginning on June 15, 2015 and expire on June 15, 2025. Dr. Biggar serves on the Board of Directors of the Issuer as a representative of Baker Brothers Life Sciences, L.P. ("Life Sciences"), 667, L.P. ("667") and 14159, L.P. ("14159", and together with 667 and Life Sciences, the "Funds"). Pursuant to the policies of the Adviser, Dr. Biggar does not have any right to any of the Issuer's securities issued as part of his service on the Board and the Funds are entitled to receive all the pecuniary interest in the securities issued. The Funds each own an indirect proportionate pecuniary interest in the Stock Options. Solely as a result of Felix J. Baker's and Julian C. Baker's ownership interest in the general partners of the general partners of the Funds, Felix J. Baker and Julian C. Baker may be deemed to have an indirect pecuniary interest in the stock options (i.e. no direct pecuniary interest).
- [F2]The Adviser serves as the Investment Adviser to the Funds. In connection with the services provided by the Adviser, the Adviser receives an asset-based management fee that does not confer any pecuniary interest in the securities held by the Funds. Baker Bros. Advisors (GP) LLC (the "Adviser GP") is the Adviser's sole general partner. Julian C. Baker and Felix J. Baker are principals of the Adviser GP. The Adviser has complete and unlimited discretion and authority with respect to the investment and voting power of the securities held by the Funds. The general partners of the Funds have relinquished to the Adviser all discretion and authority with respect to the investment and voting power of the securities held by the Funds. Pursuant to agreements between Dr. Biggar and the Adviser, the Adviser has investment and dispositive power over the Stock Options and any shares received as a result of the exercise of options. Julian C. Baker, Felix J. Baker, the Adviser GP and the Adviser disclaim beneficial ownership of the securities held directly by the Funds except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that any of Julian C. Baker, Felix J. Baker, the Adviser GP or the Adviser is a beneficial owner of such securities for purposes of Section 16 or any other purpose.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001580575
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:35 PM ET
- Size
- 18.3 KB